The Potential for Respiratory-Gated VMAT to Reduce the Normal Lung Dose When Treating Early-Stage Lung Cancer with SBRT
Byline
I Xhaferllari1 *, N Hamelin2 , J Chen1 , S Gaede1 , (1) London Regional Cancer Program, London, Ontario, CA, (2) University of Waterloo, Waterloo, Ontario, CA